{"database": "lobbying", "table": "lobbying_activities", "rows": [[2187076, "02c64356-a8dd-4dc0-a623-ac94ec8a67eb", "Q3", "PUBLIC CITIZEN", 32362, "PUBLIC CITIZEN", 2018, "third_quarter", "PHA", "S. 2852/HR 3678-Pandemic and all-hazards preparedness and advancing innovation act of 2018, HR 6294-REVAMP Act, Medicare Part D negotiation, prescription drug pricing, HR 6505-Medicare negotiation and competitive licensing act, HR 6577-PRICED act, HR 6576-Drug Price Transparency in Communications act, medicare prescription drug savings and choice act, HR 1223/S 1509 OPEN Act, S 1369-Stop Price gouging act.", "HOUSE OF REPRESENTATIVES,Office of Government Ethics (OGE),Securities & Exchange Commission (SEC),SENATE,U.S. Trade Representative (USTR)", null, 50000, 0, 0, "2018-10-17T10:26:15.573000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2187076"], "units": {}, "query_ms": 34.35024700593203, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}